Interactive drug design in virtual reality

Proceedings of the International Conference on Information Visualisation

Volumn , Issue , 2011, Pages 226-231

  Tse, Ching Man ^a   Li, Hongjian ^a   Leung, Kwong Sak ^a   Lee, Kin Hong ^a   Wong, Man Hon ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Interactive Drug Design; Virtual Reality

Indexed keywords

DRUG CANDIDATES; DRUG DESIGN; EMERGING DISEASE; FRAGMENT-BASED METHODS; TARGET PROTEINS;

ALGORITHMS; BONDING; DESIGN; LIGANDS; USER INTERFACES; VIRTUAL REALITY; VISUALIZATION;

DRUG INTERACTIONS;

EID: 80052973484     PISSN: 10939547     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IV.2011.72     Document Type: Conference Paper

References (15)

1. R. S. Bohacek, C. McMartin, and W. C. Guida, "The art and practice of structure-based drug design: A molecular modeling perspective," Medicinal Research Reviews, vol. 16, no. 1, pp. 3-50, 1996. [Online]. Available: http://dx.doi.org/10.1002/(SICI)1098-1128(199601)16:1%3C3::AID-MED1%3E3.0.CO;2- 6
2. P. J. Hajduk, W. R. J. D. Galloway, and D. R. Spring, "Drug discovery: A question of library design," Nature, vol. 470, no. 7332, pp. 42-43, Feb 2011. [Online]. Available: http://dx.doi.org/10.1038/470042a
3. G. Schneider and U. Fechner, "Computer-based de novo design of drug-like molecules," Nature Reviews Drug Discovery, vol. 4, no. 8, pp. 649-663, Aug 2005. [Online]. Available: http://dx.doi.org/10.1038/nrd1799
4. I. D. Kuntz, "Structure-based strategies for drug design and discovery," Science, vol. 257, no. 5073, pp. 1078-1082, Aug 1992.
5. P. J. Hajduk and J. Greer, "A decade of fragment-based drug design: strategic advances and lessons learned," Nat Rev Drug Discov, vol. 6, no. 3, pp. 211-219, Mar 2007. [Online]. Available: http://dx.doi.org/10.1038/nrd2220
6. R. S. Bohacek and C. McMartin, "Multiple highly diverse structures complementary to enzyme binding sites: Results of extensive application of a de novo design method incorporating combinatorial growth," Journal of the American Chemical Society, vol. 116, no. 13, pp. 5560-5571, Jun 1994. [Online]. Available: http://dx.doi.org/10.1021/ja00092a006
7. D. R. Westhead, D. E. Clark, D. Frenkel, J. Li, C. W. Murray, B. Robson, and B. Waszkowycz, "Pro-ligand: an approach to de novo molecular design. 3. a genetic algorithm for structure refinement," J. Comput. Aided Mol. Des, vol. 9, no. 2, pp. 139-148, Apr 1995.
8. J. D. Durrant, R. E. Amaro, and J. A. McCammon, "Autogrow: a novel algorithm for protein inhibitor design," Chem. Biol. Drug Des, vol. 73, no. 2, pp. 168-178, Feb 2009.
9. E.-W. Lameijer, J. N. Kok, T. Back, and A. P. IJzerman, "The molecule evoluator. an interactive evolutionary algorithm for the design of drug-like molecules," Journal of Chemical Information and Modeling, vol. 46, no. 2, pp. 545-552, 2006. [Online]. Available: http://pubs.acs.org/doi/abs/ 10.1021/ci050369d
10. E. Moritz and J. Meyer, "Interactive 3d protein structure visualization using virtual reality," in Proceedings of the 4th IEEE Symposium on Bioinformatics and Bioengineering. Washington, DC, USA: IEEE Computer Society, 2004, pp. 503-. [Online]. Available: http://portal.acm.org/ citation.cfm?id=998667.998837
11. H. M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne, "The protein data bank," Nucleic acids research, vol. 28, no. 1, pp. 235-242, January 1 2000.
12. A. Anderson and Z. Weng, "Vrdd: applying irtual eality visualization to protein ocking and esign," Journal of Molecular Graphics and Modelling, vol. 17, no. 3-4, pp. 180 - 186, 1999. [Online]. Available: http://www.sciencedirect.com/science/article/B6TGP-3YN94J2-3/2/ fe8e17c8cb8f8f0c3309af690b83b04a
13. O. Trott and A. J. Olson, "Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading," J. Comput. Chem., vol. 31, no. 2, pp. 455-461, Jan 2010.
14. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings," Adv. Drug Deliv. Rev., vol. 46, no. 1-3, pp. 3-26, Mar 2001.
15. J. J. Irwin and B. K. Shoichet, "Zinc: A free database of commercially available compounds for virtual screening," Journal of Chemical Information and Modeling, vol. 45, no. 1, pp. 177-182, 01/01 2005, doi: 10.1021/ci049714+; M3: doi: 10.1021/ci049714+. [Online]. Available: http://dx.doi.org/10.1021/ci049714+